Owl Creek Asset Management’s Celularity CELU Stock Holding History

Owl Creek Asset Management’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,900	Closed	-$1.01M	–	426
2021 Q2	$1.01M	Hold	9,900	–	–	0.05%	137
2021 Q1	$998K	Buy	+9,900	New	+$1.01M	0.03%	119
2020 Q1	–	Sell	-59,020	Closed	-$5.87M	–	103
2019 Q4	$5.87M	Buy	+59,020	New	+$5.85M	0.31%	30

Other funds holding CELU

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Owl Creek Asset Management's CELU Position: Q3 2021 in Review

Owl Creek Asset Management sold out of Celularity (CELU) in Q3 2021, closing a stake of 9,900 shares — an estimated $1.01M sold.

Owl Creek Asset Management first reported a position in CELU in Q4 2019 and held it in 3 quarters. The position peaked at $5.87M in Q4 2019. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

Owl Creek Asset Management reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
Owl Creek Asset Management sold 9,900 Celularity shares in Q3 2021, an estimated $1.01M.
Owl Creek Asset Management first reported a position in Celularity in Q4 2019 and held it in 3 quarters.
Owl Creek Asset Management's Celularity position peaked at $5.87M in Q4 2019.
21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on Owl Creek Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.